Shingles Vaccine Cuts Heart Attack Risk by 46% in Major Study
New research shows shingles vaccination dramatically reduces heart attacks, strokes, and death in people with existing heart disease.
Summary
A large study of over 246,000 Americans with heart disease found that getting a shingles vaccine reduced major cardiac events by 46% and death by 66% within one year. The vaccine appears to work by preventing shingles infections that can trigger dangerous blood clots near the heart and brain. Researchers compared people who received the Shingrix or Zostavax vaccines to unvaccinated individuals with similar health profiles. The heart protection benefits were so significant they rival those seen from quitting smoking. Scientists believe this adds to growing evidence that shingles vaccines offer benefits beyond just preventing the painful rash condition itself.
Detailed Summary
A groundbreaking study reveals that shingles vaccination provides remarkable heart protection for people already diagnosed with cardiovascular disease. Researchers analyzed data from 246,822 American adults with atherosclerotic heart disease and found those who received shingles vaccines experienced 46% fewer major cardiac events and 66% fewer deaths within one year compared to unvaccinated individuals.
The study examined people aged 50 and older between 2018-2025, comparing 123,411 vaccinated individuals to an equal number of unvaccinated controls with similar demographics and health conditions. Vaccinated participants showed across-the-board risk reductions: 32% fewer heart attacks, 25% fewer strokes, and 25% less heart failure.
Scientists believe the vaccine works by preventing shingles infections, which can trigger blood clot formation near the brain and heart. When the chickenpox virus reactivates as shingles, it increases risks of heart attacks, strokes, and dangerous clotting events. By blocking this reactivation, the vaccine appears to provide substantial cardiovascular protection.
The magnitude of benefit rivals that seen from smoking cessation, making this finding particularly significant for heart disease prevention. The research adds to mounting evidence that shingles vaccines offer benefits beyond their primary purpose, with previous studies suggesting protection against dementia and other conditions.
For adults over 50, especially those with existing heart disease, this research reinforces CDC recommendations for shingles vaccination. The findings suggest this common vaccine could be one of the most powerful yet underrecognized tools for cardiovascular protection in high-risk populations.
Key Findings
- Shingles vaccine reduced major cardiac events by 46% in people with existing heart disease
- Vaccinated individuals had 66% lower risk of death from any cause within one year
- Heart attack risk dropped 32%, stroke risk fell 25%, heart failure risk decreased 25%
- Benefits comparable to quitting smoking in magnitude of cardiovascular protection
- Study included over 246,000 Americans with atherosclerotic heart disease
Methodology
This is a news report summarizing research presented at the American College of Cardiology conference. The study used TriNetX database analysis of medical records from 2018-2025, comparing vaccinated vs unvaccinated matched cohorts.
Study Limitations
This appears to be conference presentation data, not peer-reviewed publication. The article text is incomplete, and specific statistical methods, confounding variables, and follow-up protocols require verification from primary sources.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.